Electronic Compliance Monitoring in Opioid Substitution Treatment (EHSO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01182402|
Recruitment Status : Completed
First Posted : August 16, 2010
Last Update Posted : March 22, 2011
|Condition or disease||Intervention/treatment||Phase|
|Opiate Dependence||Device: Compliance monitoring with electronic device||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||37 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Electronic Compliance Monitoring in Opioid Substitution Treatment|
|Study Start Date :||September 2010|
|Actual Primary Completion Date :||February 2011|
|Actual Study Completion Date :||February 2011|
Experimental: Electronic compliance monitoring
Suboxone treated patients in Kuopio city area get their unsupervised Suboxone doses in electronic compliance monitoring devices during the 4 month study.
Device: Compliance monitoring with electronic device
Patients get all their unsupervised substitution medication doses in electronic monitoring devices during the study. Daily dose of the drug is possible to get from the device in given time points and in the meantime device is locked.
- The effectiveness of treatment (Treatment Outcomes Profile TOP) [ Time Frame: Every two months. ]Structured interview designed to measure the effectiveness and outcomes of opioid substitution treatment.
- Patients´opinions about the treatment. [ Time Frame: Once when the study phase ends (after four months). ]Questionnaire designed for this study to explore patients` opinions on the compliance monitoring and it`s effect on their treatment and abuse and/or diversion of medications.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01182402
|Kuopio University Hospital|
|Kuopio, Finland, 70211|